Copyright
©The Author(s) 2022.
World J Clin Cases. Aug 16, 2022; 10(23): 8205-8211
Published online Aug 16, 2022. doi: 10.12998/wjcc.v10.i23.8205
Published online Aug 16, 2022. doi: 10.12998/wjcc.v10.i23.8205
Table 1 Comparison of baseline data among the five groups (mean ± SE)
| Group | n | Age (yr) | BMI (kg/m2) | Sex (male/female) |
| Normal urinary protein group | 32 | 49.34 ± 4.28 | 24.33 ± 1.65 | 15/17 |
| Microproteinuria group | 35 | 49.22 ± 4.34 | 24.31 ± 1.51 | 15/20 |
| Massive proteinuria group | 40 | 49.25 ± 4.29 | 24.52 ± 1.52 | 29/11 |
| Healthy group | 107 | 49.72 ± 4.11 | 24.49 ± 1.62 | 55/52 |
| Simple diabetes group | 107 | 49.88 ± 4.69 | 24.59 ± 1.97 | 57/50 |
| χ2/F value | - | 0.281 | 0.259 | 8.142 |
| P value | - | 0.890 | 0.904 | 0.087 |
Table 2 Comparison of changes in β2-microglobulin, glycosylated hemoglobin, and Vascular endothelial growth factor levels in the disease, healthy, and simple diabetes groups (mean ± SE)
| Group | n | β2-MG (mg/L) | HbA1c (%) | VEGF (ng/L) |
| Disease group | 107 | 4.34 ± 1.53 | 10.84 ± 1.81 | 176.69 ± 11.84 |
| Simple diabetes group | 107 | 2.56 ± 1.14 | 8.40 ± 1.24 | 137.84 ± 10.36 |
| Healthy groups | 107 | 1.11 ± 0.82 | 4.58 ± 0.95 | 109.32 ± 12.44 |
| F value | 195.518 | 558.284 | 912.281 | |
| P value | 0.000 | 0.000 | 0.000 | |
| LSD-t (disease vs simple diabetes) | 10.862 | 12.921 | 24.535 | |
| P value | 0.000 | 0.000 | 0.000 | |
| LSD-t (disease vs healthy) | 19.742 | 33.148 | 42.548 | |
| P value | 0.000 | 0.000 | 0.000 | |
| LSD-t (healthy vs simple diabetes) | 8.879 | 20.228 | 18.013 | |
| P value | 0.000 | 0.000 | 0.000 |
Table 3 Comparison of β2-microglobulin, glycosylated hemoglobin, and vascular endothelial growth factor levels among the different disease groups (mean ± SE)
| Group | n | β2-MG (mg/L) | HbA1c (%) | VEGF (ng/L) |
| Normal urinary protein group | 32 | 3.37 ± 1.32 | 9.26 ± 1.33 | 170.16 ± 10.62 |
| Microproteinuria group | 35 | 4.19 ± 1.39 | 10.57 ± 1.21 | 175.45 ± 10.39 |
| Massive proteinuria group | 40 | 5.26 ± 1.29 | 12.34 ± 1.35 | 182.99 ± 10.97 |
| F value | 18.250 | 51.067 | 13.179 | |
| P value | 0.000 | 0.000 | 0.000 | |
| LSD-t (normal urinary protein vs Microproteinuria) | 2.516 | 4.119 | 2.025 | |
| P value | 0.013 | 0.000 | 0.045 | |
| LSD-t (normal urinary protein vs massive proteinuria) | 5.981 | 9.994 | 5.066 | |
| P value | 0.000 | 0.000 | 0.000 | |
| LSD-t (microproteinuria vs massive proteinuria) | 3.471 | 5.887 | 3.051 | |
| P value | 0.001 | 0.000 | 0.003 |
Table 4 Correlation analysis
| Index | β2-MG (mg/L) | HbA1c (%) | VEGF (ng/L) | |||
| r value | P value | r value | P value | r value | P value | |
| Disease progression | 0.705 | 0.000 | 0.707 | 0.000 | 0.518 | 0.000 |
- Citation: Yang B, Zhao XH, Ma GB. Role of serum β2-microglobulin, glycosylated hemoglobin, and vascular endothelial growth factor levels in diabetic nephropathy. World J Clin Cases 2022; 10(23): 8205-8211
- URL: https://www.wjgnet.com/2307-8960/full/v10/i23/8205.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i23.8205
